About: http://data.cimple.eu/news-article/8d43666e68ef061dd486bd72a9637e2f517fd845445ddb6e4df74130     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • Australian researchers are fast-tracking large-scale human testing to see if a vaccine used for decades to prevent tuberculosis can protect health workers from COVID-19, they announced Friday. The trial of the BCG vaccine will be conducted with 4,000 health workers in hospitals around Australia to determine if it can reduce COVID-19 symptoms, the researchers at the Murdoch Children's Research Institute in Melbourne said. "Although originally developed against tuberculosis, and still given to over 130 million babies annually for that purpose, BCG also boosts humans' 'frontline' immunity, training it to respond to germs with greater intensity," they said in a statement. "We hope to see a reduction in the prevalence and severity of COVID-19 symptoms in healthcare workers receiving the BCG vaccination," said lead researcher Nigel Curtis. He said the 4,000 subjects would be enrolled in the trial within weeks under a fast-tracked process with the approval of state and federal health authorities. "The clock is definitely ticking," he said. Similar trials are being conducted in several other countries including the Netherlands, Germany and the United Kingdom. "This trial will allow the vaccine's effectiveness against COVID-19 symptoms to be properly tested, and may help save the lives of our heroic frontline healthcare workers," said Kathryn North, director of the Murdoch Institute. She said the hope was that improving people's "innate" immunity against COVID-19 symptoms would buy time to develop a specific vaccine against the disease. "These trials will allow the rapid advancement of the most promising candidates to clinical practice, giving us the most number of shots on goal against COVID-19 as possible," she said. dm/bgs
schema:headline
  • Australians trial TB vaccine to fight coronavirus
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
http://data.cimple...tology#hasEmotion
http://data.cimple...entionsConspiracy
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software